Gabriel Boyle
Impact in
-
- Parkinson's Disease Mechanisms and Treatments
-
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
-
- Nuclear Receptors and Signaling 2
- Co-authors
- Maitreya J. Dunham (3 shared papers)Douglas M. Fowler (4 shared papers)Sylvain Lesné (3 shared papers)Allan E. Rettie (2 shared papers)Katherine A. Sitko (2 shared papers)Matthew G. McDonald (1 shared paper)Michael K. Lee (3 shared papers)Melissa A. Chiasson (1 shared paper)
- Journals
- Genetics (1 paper)Acta Neuropathologica (1 paper)PLoS Biology (1 paper)The Annual Review of Pharmacology and Toxicology (1 paper)Acta Neuropathologica Communications (1 paper)
- Partner nations
- United StatesSouth AfricaAustralia
In The Last Decade
Gabriel Boyle
8 papers receiving 173 citations
Peers
Comparison fields: 5 of 43
- Neurology 51
- Pharmacology 22
- Biological Psychiatry 5
- Physiology 44
- Neurology 11
Countries citing papers authored by Gabriel Boyle
This map shows the geographic impact of Gabriel Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Boyle more than expected).
Fields of papers citing papers by Gabriel Boyle
This network shows the impact of papers produced by Gabriel Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Boyle. The network helps show where Gabriel Boyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Boyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 68 | |
| 2 | 2017 | 49 | |
| 3 | 2018 | 28 | |
| 4 | 2021 | 13 | |
| 5 | 2024 | 6 | |
| 6 | 2022 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2025 | 2 | |
| 9 | 2026 | 0 |
About Gabriel Boyle
Gabriel Boyle is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Neurology, Molecular Biology and Physiology, having authored 9 papers that have together received 173 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Alzheimer's disease research and treatments (2 papers), Nuclear Receptors and Signaling (2 papers), Statistical Methods in Clinical Trials (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Genomics and Rare Diseases (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Neurology (51 citations), Pharmacology (22 citations), Biological Psychiatry (5 citations), Physiology (44 citations) and Neurology (11 citations). Gabriel Boyle has collaborated with scholars based in United States, South Africa and Australia. Frequent co-authors include Maitreya J. Dunham, Douglas M. Fowler, Sylvain Lesné, Allan E. Rettie, Katherine A. Sitko, Matthew G. McDonald, Michael K. Lee, Melissa A. Chiasson, Lai Hong Wong and Mathew A. Sherman. Their work appears in journals such as Genetics, Acta Neuropathologica, PLoS Biology, The Annual Review of Pharmacology and Toxicology and Acta Neuropathologica Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.